$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000168316823002065 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$236.1K	$71.16K	$353.6K
YoY Change	50.22%	-59.23%	-75.35%
Cost Of Revenue	$180.7K	$87.90K	$330.9K
YoY Change	26.31%	-23.15%	-70.88%
Gross Profit	$55.35K	-$16.74K	$22.72K
YoY Change	293.12%	-127.83%	-92.38%
Gross Profit Margin	23.44%	-23.52%	6.42%
Selling, General & Admin	$454.9K	$845.5K	$2.216M
YoY Change	-51.57%	0.45%	57.99%
% of Gross Profit	821.87%		9755.56%
Research & Development	$276.5K	$198.2K	$1.060M
YoY Change	-50.78%	263.15%	380.97%
% of Gross Profit	499.5%		4667.19%
Depreciation & Amortization	$42.04K	$42.36K	$166.3K
YoY Change	4.67%	5.29%	2.53%
% of Gross Profit	75.95%		731.8%
Operating Expenses	$1.296M	$1.086M	$5.228M
YoY Change	-37.71%	15.94%	17.46%
Operating Profit	-$1.241M	-$1.102M	-$5.206M
YoY Change	-35.5%	25.81%	72.57%
Interest Expense	$32.11K	$1.000K	-$17.32K
YoY Change	-321200.0%	-228.21%	-97.76%
% of Operating Profit
Other Income/Expense, Net	$126.7K	-$111.8K	$278.7K
YoY Change	130.71%	-343.72%	-236.36%
Pretax Income	-$1.114M	-$1.055M	-$4.927M
YoY Change	-40.38%	46.37%	52.96%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.114M	-$1.055M	-$4.927M
YoY Change	-40.38%	46.37%	52.96%
Net Earnings / Revenue	-471.95%	-1482.14%	-1393.29%
Basic Earnings Per Share	-$0.02		-$0.11
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.11
COMMON SHARES
Basic Shares Outstanding	43.23M shares	43.53M shares	43.41M shares
Diluted Shares Outstanding	45.15M shares		43.41M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.622M	$4.449M	$4.449M
YoY Change	-66.15%	-48.74%	-48.74%
Cash & Equivalents	$2.570M	$4.343M	$4.343M
Short-Term Investments	$51.40K	$105.5K	$105.5K
Other Short-Term Assets	$222.9K	$142.3K	$142.3K
YoY Change	40.54%	-53.67%	-53.67%
Inventory	$90.66K	$103.8K	$103.8K
Prepaid Expenses	$222.9K	$142.3K
Receivables	$64.37K	$78.31K	$112.8K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.000M	$4.808M	$4.808M
YoY Change	-63.74%	-47.82%	-47.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.197M	$4.229M	$4.482M
YoY Change	-3.41%	-2.86%	-6.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.82K	$33.26K	$33.26K
YoY Change	-64.14%	-1.97%	-1.97%
Total Long-Term Assets	$4.492M	$4.515M	$4.515M
YoY Change	-4.11%	-6.08%	-6.08%
TOTAL ASSETS
Total Short-Term Assets	$3.000M	$4.808M	$4.808M
Total Long-Term Assets	$4.492M	$4.515M	$4.515M
Total Assets	$7.492M	$9.323M	$9.323M
YoY Change	-42.19%	-33.51%	-33.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$214.7K	$267.7K	$267.7K
YoY Change	-35.12%
Accrued Expenses	$82.39K	$113.1K	$113.1K
YoY Change	-35.92%	-7.0%	-7.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$402.4K	$1.387M	$1.387M
YoY Change	-35.59%	142.76%	142.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$12.34K	$12.34K	$178.3K
YoY Change	-16.29%		-41.04%
Total Long-Term Liabilities	$159.5K	$178.3K	$178.3K
YoY Change	-14.91%	-45.7%	-45.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$402.4K	$1.387M	$1.387M
Total Long-Term Liabilities	$159.5K	$178.3K	$178.3K
Total Liabilities	$562.0K	$1.566M	$1.566M
YoY Change	-30.82%	73.99%	73.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$18.98M	-$17.86M
YoY Change	28.18%	38.08%
Common Stock	$64.77K	$43.53K
YoY Change	49.72%	0.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$2.000M
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.930M	$7.758M	$7.758M
YoY Change
Total Liabilities & Shareholders Equity	$7.492M	$9.323M	$9.323M
YoY Change	-42.19%	-33.51%	-33.51%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.114M	-$1.055M	-$4.927M
YoY Change	-40.38%	46.37%	52.96%
Depreciation, Depletion And Amortization	$42.04K	$42.36K	$166.3K
YoY Change	4.67%	5.29%	2.53%
Cash From Operating Activities	-$838.5K	-$522.8K	-$2.958M
YoY Change	-7.07%	-28.54%	32.74%
INVESTING ACTIVITIES
Capital Expenditures	$9.920K	$3.000K	$42.19K
YoY Change	-68.48%	-118.62%	83.5%
Acquisitions
YoY Change
Other Investing Activities	$71.74K	-$30.52K	-$169.1K
YoY Change
Cash From Investing Activities	$61.82K	-$33.52K	-$211.3K
YoY Change	-296.45%	108.07%	818.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.000M	-1.159M	-$1.159M
YoY Change		965.33%	-111.2%
NET CHANGE
Cash From Operating Activities	-$838.5K	-522.8K	-$2.958M
Cash From Investing Activities	$61.82K	-33.52K	-$211.3K
Cash From Financing Activities	-$1.000M	-1.159M	-$1.159M
Net Change In Cash	-$1.773M	-1.715M	-$4.335M
YoY Change	89.88%	100.23%	-153.55%
FREE CASH FLOW
Cash From Operating Activities	-$838.5K	-$522.8K	-$2.958M
Capital Expenditures	$9.920K	$3.000K	$42.19K
Free Cash Flow	-$848.5K	-$525.8K	-$3.000M
YoY Change	-9.13%	-26.51%	33.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	FCUV	Stock Based Compensation Cashless Exercise Option StockBasedCompensationCashlessExerciseOption		usd
CY2022	FCUV	Stock Issued During Period Value Issued For Prior Services StockIssuedDuringPeriodValueIssuedForPriorServices		usd
CY2022	FCUV	Shares Issued For Cashless Exercise Of Warrants Value SharesIssuedForCashlessExerciseOfWarrantsValue		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-193087
CY2022	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3355876
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2311 East Locust Court
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Ontario
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91761
CY2022	dei	City Area Code CityAreaCode	(626)
CY2022	dei	Local Phone Number LocalPhoneNumber	272-3883
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2022	dei	Trading Symbol TradingSymbol	FCUV
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	495782364	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43229653	shares
CY2022	dei	Auditor Firm AuditorFirmId	6906
CY2022	dei	Auditor Name AuditorName	Reliant CPA PC
CY2022	dei	Auditor Location AuditorLocation	Newport Beach, CA
CY2022Q4	us-gaap	Cash Cash	4343426	usd
CY2021Q4	us-gaap	Cash Cash	8678665	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78313	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	177315	usd
CY2022Q4	FCUV	Accounts Receivable Related Party AccountsReceivableRelatedParty	34507	usd
CY2021Q4	FCUV	Accounts Receivable Related Party AccountsReceivableRelatedParty	15176	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	22889	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	0	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	13057	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	142342	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	301270	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	105470	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	5968	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4807830	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9214340	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4353340	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	420137	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33264	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	33933	usd
CY2022Q4	us-gaap	Assets Assets	9323060	usd
CY2021Q4	us-gaap	Assets Assets	14021750	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	267685	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	293354	usd
CY2022Q4	FCUV	Treasury Stock Payable TreasuryStockPayable	1000000	usd
CY2021Q4	FCUV	Treasury Stock Payable TreasuryStockPayable	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6496	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23902	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	132618	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121568	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1387239	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	571442	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	302387	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25929	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12335	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	178287	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	328316	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1565526	usd
CY2021Q4	us-gaap	Liabilities Liabilities	899758	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43530915	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43530915	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43259741	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43259741	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43531	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	43259	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	400000	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2000000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	-0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27536499	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24093075	usd
CY2022Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	48075	usd
CY2021Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	1922753	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17864028	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12937091	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6543	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9323060	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14021750	usd
CY2022	us-gaap	Revenues Revenues	353619	usd
CY2021	us-gaap	Revenues Revenues	1434446	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	330899	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1137287	usd
CY2022	us-gaap	Gross Profit GrossProfit	22720	usd
CY2021	us-gaap	Gross Profit GrossProfit	297159	usd
CY2022	us-gaap	Selling Expense SellingExpense	142372	usd
CY2021	us-gaap	Selling Expense SellingExpense	39821	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	1055133	usd
CY2021	us-gaap	Officers Compensation OfficersCompensation	661171	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1060385	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220469	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	896385	usd
CY2021	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	1030159	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2074091	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1362126	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5228366	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	3313746	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5205646	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3016587	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3887	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-37608	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	158547	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	371118	usd
CY2022	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	0	usd
CY2021	FCUV	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1284780	usd
CY2022	FCUV	Gain On Settlements Of Derivative Liability GainOnSettlementsOfDerivativeLiability	0	usd
CY2021	FCUV	Gain On Settlements Of Derivative Liability GainOnSettlementsOfDerivativeLiability	550406	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-42395	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-21205	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2022	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	166288	usd
CY2021	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	186212	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	13587	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10262	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	278709	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-204390	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4926937	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3220977	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3220977	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	6539	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	4	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4933476	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3220981	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43413080	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43413080	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41715905	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41715905	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4804612	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11060505	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	429856	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3220977	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13121992	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	849043	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	711975	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2000000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6539	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7757534	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4926937	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3220977	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	136337	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	42116	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-27199	usd
CY2021	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-1622	usd
CY2022	us-gaap	Depreciation Depreciation	166266	usd
CY2021	us-gaap	Depreciation Depreciation	162160	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-42395	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-0	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-21205	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-0	usd
CY2022	FCUV	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-0	usd
CY2021	FCUV	Changes In Fair Value Of Warrant Liability ChangesInFairValueOfWarrantLiability	-1284780	usd
CY2022	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	-0	usd
CY2021	FCUV	Gain On Settlement Of Derivative Liability GainOnSettlementOfDerivativeLiability	550406	usd
CY2022	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	719975	usd
CY2021	FCUV	Share Based Compensation Shares ShareBasedCompensationShares	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	48000	usd
CY2022	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	849043	usd
CY2021	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	429856	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37335	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28875	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	19331	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	15176	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53684	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-21229	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-13057	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13057	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-158474	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	210017	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-4035	usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-66767	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	139754	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-333140	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-21722	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	94484	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17471	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17135	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	17299	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-271	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-57106	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-117245	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	328846	usd
CY2022	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	12335	usd
CY2021	FCUV	Increase Decrease In Other Liabilities IncreaseDecreaseInOtherLiabilities	-17135	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2957983	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1969445	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42187	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22990	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	768949	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	599879	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-211257	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22990	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	267297	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	-0	usd
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	246650	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1500000	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	-0	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1500000	usd
CY2022	FCUV	Forgiveness Of Debt ForgivenessOfDebt	158547	usd
CY2021	FCUV	Forgiveness Of Debt ForgivenessOfDebt	258960	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	10326131	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1158547	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10087818	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7452	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-43	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4335239	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8095340	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	583325	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4343426	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8678665	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	12164	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	42968	usd
CY2022	FCUV	Cashless Warrant CashlessWarrant	0	usd
CY2021	FCUV	Cashless Warrant CashlessWarrant	1776044	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ztpWmXn1byh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_862_z8H1iFWWHepb">Reclassification</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the consolidated financial statements for prior years to the current year’s presentation. Such reclassifications have no effect on net income as previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_z7wICiCGkMA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zaFOGiOrnLni">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of use asset and lease liability, useful lives of property and equipment, useful lives of intangible assets, allowance for doubtful accounts, inventory reserves, debt discounts, valuation of derivatives, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3120763	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	7464846	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	222972	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	86635	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zW6VSWpiVo39" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_862_zMRJInK0gvnc">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	41741	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	68940	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	305616	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	315288	shares
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	3767	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	12470	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	100005	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10419	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	103772	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	22889	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4902400	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4860948	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673770	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	507608	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4228630	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4353340	usd
CY2022	us-gaap	Depreciation Depreciation	166266	usd
CY2021	us-gaap	Depreciation Depreciation	162160	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	209738	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	67664	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	253336	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	420137	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	113058	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	121568	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	165952	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	302387	usd
CY2022Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y2M1D
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	135929	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	151173	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	25407	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	312509	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	33499	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	279010	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	0	usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable	158547	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	-0	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	132618	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	25929	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	271174	shares
CY2021	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2300000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43259741	shares
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1041670	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2326450	usd
CY2022Q4	FCUV	Value Of Shares To Be Issued ValueOfSharesToBeIssued	0	usd
CY2021Q4	FCUV	Value Of Shares To Be Issued ValueOfSharesToBeIssued	1284780	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.25	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1034596	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-673266	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-435516	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-283413	usd
CY2022	FCUV	Income Tax Reconciliation Foreign Income Tax IncomeTaxReconciliationForeignIncomeTax	-129904	usd
CY2021	FCUV	Income Tax Reconciliation Foreign Income Tax IncomeTaxReconciliationForeignIncomeTax	-857	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-86	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-3439	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1600102	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	960975	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5261884	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	3661868	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	43786	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	43700	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5305670	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3705568	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5305670	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3705568	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1600102	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	3611045	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	12268804	usd
CY2022	FCUV	Future Taxable Income FutureTaxableIncome	4926649	usd

Files In Submission

Name	View Source	Status
0001683168-23-002065-index-headers.html	Edgar Link	pending
0001683168-23-002065-index.html	Edgar Link	pending
0001683168-23-002065.txt	Edgar Link	pending
0001683168-23-002065-xbrl.zip	Edgar Link	pending
fcuv-20221231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
focus_ex1007.htm	Edgar Link	pending
focus_ex1008.htm	Edgar Link	pending
focus_ex1010.htm	Edgar Link	pending
focus_ex1011.htm	Edgar Link	pending
focus_ex1012.htm	Edgar Link	pending
focus_ex1013.htm	Edgar Link	pending
focus_ex1014.htm	Edgar Link	pending
focus_ex3101.htm	Edgar Link	pending
focus_ex3102.htm	Edgar Link	pending
focus_ex3201.htm	Edgar Link	pending
focus_ex3202.htm	Edgar Link	pending
focus_i10k-123122.htm	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
image_023.jpg	Edgar Link	pending
image_025.jpg	Edgar Link	pending
image_028.jpg	Edgar Link	pending
image_029.jpg	Edgar Link	pending
image_046.jpg	Edgar Link	pending
image_047.jpg	Edgar Link	pending
fcuv-20221231_def.xml	Edgar Link	unprocessable
fcuv-20221231_lab.xml	Edgar Link	unprocessable
fcuv-20221231_pre.xml	Edgar Link	unprocessable
focus_i10k-123122_htm.xml	Edgar Link	completed
image_048.jpg	Edgar Link	pending
image_049.jpg	Edgar Link	pending
image_050.jpg	Edgar Link	pending
image_051.jpg	Edgar Link	pending
image_052.jpg	Edgar Link	pending
image_053.jpg	Edgar Link	pending
image_054.jpg	Edgar Link	pending
image_055.jpg	Edgar Link	pending
image_056.jpg	Edgar Link	pending
image_057.jpg	Edgar Link	pending
image_058.jpg	Edgar Link	pending
image_059.jpg	Edgar Link	pending
image_060.jpg	Edgar Link	pending
image_061.jpg	Edgar Link	pending
image_062.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fcuv-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q1 Form 10-K Financial Statement

#000168316823002065 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2023 Q1 Form 10-K Financial Statement

#000168316823002065 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv